Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1957 ARTÍCULOS , VIENDO DEL 1576 AL 1590

Deciphering the peripheral immune landscape of Alzheimer's disease through integrated multi-omics research and cohort validation

Lv S, Kuang JY, Wang TW, Zhang LP, Liu J, Wang WD, Yang MF, Ni QB, Sun BL, Sun JY.

Front Immunol. 2026 Apr 13;17:1648591. doi: 10.3389/fimmu.2026.1648591. eCollection 2026.

Progress in Machine Learning-Assisted Biosensors for Alzheimer's Disease

Feng Y, Chen C.

Biosensors (Basel). 2026 Mar 13;16(3):161. doi: 10.3390/bios16030161.

Plasma Biomarkers and Clinical Outcomes in Early-Onset Dementia

Jang H, Lee SM, Kim HJ, Jung NY, Zetterberg H, Blennow K, Apostolova LG, Moon SY, Kim EJ; Longitudinal Study of Early-Onset Dementia and Family Members (LEAF) Investigators.

JAMA Netw Open. 2026 Apr 1;9(4):e269687. doi: 10.1001/jamanetworkopen.2026.9687.

The Role of Magnetic Resonance Spectroscopy (MRS), Diffusion-Tensor-Imaging (DTI) and Structural MRI in the Alzheimer's Disease and Mild Cognitive Impairment Diagnosis: A Review

Zecca V, Palombelli G, Vanacore N, Canese R.

J Magn Reson Imaging. 2026 Jun;63(6):1509-1545. doi: 10.1002/jmri.70296. Epub 2026 Mar 19.

Precision pathways: optimising amyloid PET for sustainable Alzheimer's disease care

Morbelli SD, Bozzali M, Cagnin A, Cecchin D, Chiti A, Filippi M.

J Neurol. 2026 May 26;273(6):340. doi: 10.1007/s00415-026-13874-2.

Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population

Russell JK, Schlachetzki Z, Rafii MS.

Curr Opin Neurol. 2026 Apr 1;39(2):210-216. doi: 10.1097/WCO.0000000000001461. Epub 2026 Feb 18.

Head-to-head comparison of brain-derived pTau217 and total pTau217 for brain amyloid and tau pathology classification

Jiang Y, Zheng W, Xia Z, Wong WW, Cheng LKW, Ip FC, Choi SM, Chan ALT, Lam CY, Ho KS, Shum CK, Yuen JKY, Shea YF, Wai HM, Mok VCT, Kwok TCY, Mok KY, Wong HY, Zetterberg H, Fu AKY, Ip NY.

Proc Natl Acad Sci U S A. 2026 Mar 10;123(10):e2536792123. doi: 10.1073/pnas.2536792123. Epub 2026 Mar 2.

Multi-omics integration reveals shared genetic architecture between metabolic markers and gray matter atrophy in Alzheimer's Disease

Wang P, Wu X, Sun F, Zhang H, Jiang Y, Wang Q, Ding H, Zhou Y, Liu F, Liu H.

J Prev Alzheimers Dis. 2026 Feb;13(2):100452. doi: 10.1016/j.tjpad.2025.100452. Epub 2026 Jan 1.

The Right Person, the Right Treatment, at the Right Time in Alzheimer's Disease: Insights From the 2025 Brain Aging Symposium

de Magalhães CG, Moldakozhayev A, Lopez MV, Bowman GL, Chhatwal JP, Kellis M, Mohs R, Nisenbaum L, Quiroz YT, Raju RM, Sperling RA, Moqri M, Gladyshev VN.

Aging Cell. 2026 Jan;25(1):e70351. doi: 10.1111/acel.70351.

Synaptic biomarkers in Alzheimer's disease dementia and mild cognitive impairment: A systematic review and meta-analysis

Gaur A, Wong M, Chen JJ, Kang Y, Tahoulas D, Jeor K, Raguram KH, Gallagher D, Rapoport M, Herrmann N, Lanctôt KL.

Alzheimers Dement. 2026 May;22(5):e71501. doi: 10.1002/alz.71501.

The role of MicroRNAs in Alzheimer's disease: from pathogenesis to therapeutic potential

Zhou Y, Li S, Xiang J.

Mol Biol Rep. 2026 Mar 31;53(1):558. doi: 10.1007/s11033-026-11746-6.

Tau and β-Amyloid Relevant Pathology as a Central Therapeutic Target in Alzheimer's Disease

Strużyńska L, Adamiak K, Sidoryk-Węgrzynowicz M.

Biomolecules. 2026 Apr 17;16(4):595. doi: 10.3390/biom16040595.

Consensus statement on the use of Alzheimer's disease biomarkers and anti-amyloid therapies in Hong Kong

Shum CK, Shea YF, Au Yeung TW, Chan CCY, Chan WC, Cheng WK, Cheung NYF, Cho DHY, Chow TK, Fong GCY, Ip BYM, Kwok JSH, Lai BMH, Lam LCW, Lee ATC, Lok CM, Mok KY, Ng DKK, Siu DYW, Yeung PY, Tam SKF.

Hong Kong Med J. 2026 Apr;32(2):144-154. doi: 10.12809/hkmj2514198. Epub 2026 Apr 13.

FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer's Disease: Where Are We Now?

Higgins M, Wasef V, Kwakowsky A.

Int J Mol Sci. 2026 Jan 15;27(2):883. doi: 10.3390/ijms27020883.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias